ARQT - Conference and earnings call announcements

WESTLAKE VILLAGE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will present at the Goldman Sachs 47th Annual Global Healthcare Conference, taking place June 8-10, 2026, in Miami. Details for the Company's participation are as follows:        Fireside Chat: Tuesday, June 9, 2026, at 2:00 p.m. ET The webcast for this conference may be accessed via the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. Ab

VANCOUVER, British Columbia, April 08, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary — Biotechs that went public in Q1 2026 raised a median of $287.5 million each; and nearly every one of them carried mid or late stage clinical data[1]. That is not a coincidence. The IQVIA Institute's latest annual report found that biopharma dealmaking is now clustering around high value science and companies with credentialed pipelines[2]. It's becoming apparent that smart money is no longer chasing press releases, it's chasing invitations. Conference stage presentations from field defining researchers, peer reviewed journal publications, and stacked regulatory designations have become the fi

WESTLAKE VILLAGE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will present at the 25th Annual Needham Virtual Healthcare Conference, taking place April 13-16, 2026. Details for the Company's participation are as follows:        Fireside Chat: Tuesday, April 14, 2026 at 11:00 am ET The webcast for this conference may be accessed via the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. About Arcutis

WESTLAKE VILLAGE, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will present at the TD Cowen 46th Annual Health Care Conference, taking place March 2-4, 2026, in Boston. Details for the Company's participation are as follows:     Fireside Chat: Monday, March 2, 2026 at 1:50 p.m. ET The webcast for this conference may be accessed via the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. About ArcutisAr

WESTLAKE VILLAGE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in two upcoming investor conferences. Details for the company's participation are as follows: Guggenheim's 2nd Annual Healthcare Innovation Conference, November 10-12, 2025        Fireside Chat Date: Tuesday, November 11, 2025        Fireside Chat Time: 8:30 am ET TD Cowen Immunology & Inflammation Summit, November 12-13, 2025        Fireside Chat Date: Wednesday, November 12, 2025        Fireside Chat Time: 9:00 am E

WESTLAKE VILLAGE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in three upcoming investor conferences. Details for the company's participation are as follows: Citi's 2025 Biopharma Back to School Conference, September 2-3, 2025 Fireside Chat Date: Wednesday, September 3, 2025 Fireside Chat Time: 9:45 am EDT  Morgan Stanley's 23rd Annual Global Healthcare Conference, September 8-10, 2025 Fireside Chat Date: Tuesday, September 9, 2025 Fireside Chat Time: 2:35pm EDT  HC Wainwright 27t

WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Goldman Sachs 46th Annual Global Healthcare Conference, taking place June 9-11, 2025. Details for the company's participation are as follows:        Fireside Chat Date: Tuesday, June 10, 2025        Fireside Chat Time: 4:00 pm EDT The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days followin

Once-daily ZORYVE foam provides powerful clearance and rapid itch relief from head to toe with no limitation on duration of useMore than half of the nearly 9 million people in the United States with plaque psoriasis experience scalp involvementHealthcare providers and individuals with plaque psoriasis can now choose ZORYVE foam or cream to treat plaque psoriasis anywhere it appears on the bodyFifth FDA approval for ZORYVE in less than three yearsManagement will host an investor event with a key opinion leader on Monday, June 2 at 8:00 am ET/5:00 am PT WESTLAKE VILLAGE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutica

WESTLAKE VILLAGE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the 24th Annual Needham Virtual Healthcare Conference, taking place April 7–10, 2025. Details for the company's participation are as follows:        Fireside Chat Date: Tuesday, April 8, 2025        Fireside Chat Time: 11:00 am EDT The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following

WESTLAKE VILLAGE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the TD Cowen 45th Annual Health Care Conference, taking place March 3-5, 2025. Details for the company's participation are as follows:        Fireside Chat Date: Tuesday, March 4, 2025        Fireside Chat Time: 9:50 am EST The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conf

WESTLAKE VILLAGE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Guggenheim SMID Cap Biotech Conference, taking place February 5-6, 2025. Details for the company's participation are as follows:        Fireside Chat Date: Thursday, February 6, 2025        Fireside Chat Time: 1:00 pm ET The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the con

WESTLAKE VILLAGE, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference. Details for the company's participation are as follows: Fireside Chat Date: Thursday, September 5, 2024Fireside Chat Time: 1:50 pm ET The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. About Arcut

WESTLAKE VILLAGE, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, taking place June 10-13, 2024. Details for the company's participation are as follows: Fireside Chat Date: Wednesday, June 12, 2024Fireside Chat Time: 1:20 pm ET The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the

WESTLAKE VILLAGE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the 23rd Annual Needham Virtual Healthcare Conference, taking place April 8-11, 2024. Details for the company's participation are as follows:  Fireside Chat Date: Thursday, April 11, 2024 Fireside Chat Time: 2:15 pm EDT   The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the confer

Late breaking sessions to highlight new data from the INTEGUMENT-PED trial evaluating roflumilast cream 0.05% in children ages 2-5 with atopic dermatitisNew patient-reported outcomes including pruritus data from two pooled Phase 3 trials (DERMIS-1 and DERMIS-2) of ZORYVE® (roflumilast) cream 0.3% in plaque psoriasisNew efficacy and patient-reported outcome data of ZORYVE (roflumilast) topical foam, 0.3%, in seborrheic dermatitis and investigational roflumilast foam in scalp and body psoriasis WESTLAKE VILLAGE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations i

WESTLAKE VILLAGE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the TD Cowen 44th Annual Health Care Conference. Details for the company's participation are as follows: Fireside Chat Date: Monday, March 4, 2024Fireside Chat Time: 2:10 pm ET The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. About ArcutisArcutis Biotherapeutics,

WESTLAKE VILLAGE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference. Details for the company's participation are as follows: Fireside Chat Date: Wednesday, February 7, 2024Fireside Chat Time: 10:00 am ET The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. About Ar

WESTLAKE VILLAGE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in an upcoming investor conference. Details for the company's participation are as follows: Morgan Stanley 21st Annual Global Healthcare ConferenceFireside Chat Date: Tuesday, September 12, 2023Fireside Chat Time: 2:55 pm ET The webcast for this conference may be accessed at the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. Ab

WESTLAKE VILLAGE, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in an upcoming investor conference. Details for the company's participation are as follows: Goldman Sachs 44th Annual Global Healthcare ConferenceFireside Chat Date: Tuesday, June 13, 2023Fireside Chat Time: 10:40am PT / 1:40 pm ET The webcast for this conference may be accessed at the "Events" section of the Company's website. The replay of the webcast will be available on the Arcutis website for 180 days following the confere

ZORYVE™ (roflumilast cream 0.3%), first topical PDE4 inhibitor approved for the treatment of plaque psoriasis1Once daily steroid-free cream can be used across all body areas affected by plaque psoriasis, including sensitive intertriginous areas (areas of skin-to skin contact), for any duration1Clinical data for ZORYVE show rapid clearance of psoriasis plaques and reduction of symptoms, including itch1,2,3TORONTO, May 1, 2023 /CNW/ - Arcutis Canada Inc., is pleased to announce that Health Canada has approved ZORYVE™ (roflumilast cream 0.3%), the first topical phosphodiesterase-4 (PDE4) inhibitor for topical treatment of plaque psoriasis, including treatment of psoriasis in the intertriginous

WESTLAKE VILLAGE, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in an upcoming investor conference. Details for the company's participation are as follows: 22nd Annual Needham Virtual Healthcare ConferenceFireside Chat Date: Tuesday, April 18, 2023Fireside Chat Time: 11:45 a.m. ET The webcast for this conference may be accessed at the "Events" section of the Company's website. The replay of the webcast will be available on the Arcutis website for 90 days following the conference. About Ar

WESTLAKE VILLAGE, Calif., Nov. 11, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in an upcoming investor conference. Details for the company's participation are as follows: Guggenheim 4th Annual Immunology and Neurology DayFireside Chat Date: Tuesday, November 15, 2022Fireside Chat Time: 10:45 a.m. ET The webcast for this conference may be accessed at the "Events" section of the Company's website. The replay of the webcast will be available on the Arcutis website for 30 days following the conference. About

WESTLAKE VILLAGE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in an upcoming investor conference. Details for the company's participation are as follows: Morgan Stanley 20th Annual Global Healthcare ConferenceFireside Chat Date: Tuesday, September 13, 2022Fireside Chat Time: 8:00 a.m. EDT The webcast for this conference may be accessed at the "Events" section of the Company's website. The replay of the webcast will be available on the Arcutis website for 180 days following th

WESTLAKE VILLAGE, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in an upcoming investor conference. Details for the company's participation are as follows: Cowen 42nd Annual Health Care Conference (Virtual)Fireside Chat Date: Monday, March 7, 2022Fireside Chat Time: 2:50 p.m. EST Webcasts for this conference may be accessed at the "Events" section of the Company's website. The replay of the webcast will be available on the Arcutis website for 90 days following the conference.

WESTLAKE VILLAGE, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions, today announced that Arcutis management will participate in an upcoming investor conference in November. Details for the company's participation are as follows: Guggenheim 3rd Annual Neuro/Immunology Conference (Virtual)Fireside Chat Date: Tuesday, November 16, 2021Fireside Chat Time: 1:00 p.m. EST Webcasts for this conference may be accessed at the "Events & Presentations"

WESTLAKE VILLAGE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions, today announced that Arcutis management will participate in two upcoming investor conferences in September. Details for the company's participation are as follows: Morgan Stanley 19th Annual Global Healthcare ConferenceFireside Chat Date: Wednesday, September 15, 2021Fireside Chat Time: 10:15 a.m. EDT Cantor Virtual Global Healthcare ConferenceFireside Chat

WESTLAKE VILLAGE, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Arcutis management will participate in a virtual fireside chat during the 2021 Truist Securities Life Sciences Summit taking place May 4-5, 2021. Details for the presentation are as follows:         2021 Truist Securities Life Sciences Summit         Fireside Chat Date: Wednesday, May 5, 2021         Fireside Chat Time: 1:00 p.m. ET The presentation will be webcast and may be

WESTLAKE VILLAGE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Arcutis management will participate in a virtual presentation during the Cowen 41st Annual Health Care Conference taking place March 1-4, 2021. Details for the presentation are as follows:         Cowen 41st Annual Health Care Conference         Presentation Date: Monday, March 1, 2021         Presentation Time: 12:20 p.m. PT / 3:20 p.m. ET The presentation will be webcast an